Senior Brain Health

A Fall Changes
Everything — Unless
You See It Coming

1 in 4 adults over 65 falls every year. Falls are the leading cause of brain injury death in older adults — and most of the neurological changes that lead to falls and cognitive decline can be detected in the eyes years before a crisis. ClearGazeTest's 5-minute assessment reads those signals. No MRI. No specialist wait. No guesswork.

🧠
The Brain Changes Before the Fall
Neurological decline that increases fall risk — changes in gaze control, balance integration, and processing speed — shows up in eye movement data before balance problems become obvious.
👁️
Eyes Reveal Cognitive Change Early
Eye movement patterns are among the earliest detectable markers of cognitive decline. Changes in saccade latency and smooth pursuit gain appear in mild cognitive impairment years before a dementia diagnosis.
⏱️
5 Minutes. No Imaging Required.
The complete ClearGazeTest assessment takes under 5 minutes and requires no MRI, no contrast dye, and no specialist appointment. Results are available immediately for your care team.
📊
Objective Data, Not Impressions
12 neurological biomarkers — measured, quantified, and tracked over time. Changes that are invisible to family and primary care physicians become visible in the data.
1 in 4
Adults over 65 fall each year — most causing serious injury
CDC · 2024
#1
Cause of TBI death in adults over 65 is a fall
CDC INJURY CENTER
$50B
Annual cost of falls in older adults — projected to reach $101B by 2030
NATIONAL COUNCIL ON AGING
5 min
Complete ClearGazeTest neurological assessment — no imaging, no wait
CLEARGAZETEST PLATFORM
The Connection

The Brain, the Eyes,
and Healthy Aging

The eyes are the most direct window into the aging brain. Eye movements are controlled by a distributed network spanning the frontal cortex, cerebellum, brainstem, and vestibular system — the same systems that govern balance, reaction time, and cognitive processing.

As the brain ages, these systems change — and those changes show up in eye movement data with remarkable sensitivity. Subtle increases in saccadic latency, degraded smooth pursuit tracking, and reduced contrast sensitivity are measurable years before they produce visible symptoms like falls, gait instability, or memory complaints.

After a fall or head injury, older adults are particularly vulnerable. The aging brain has less neurological reserve, slower recovery, and greater vulnerability to second impacts. A concussion at 72 is not the same injury as a concussion at 22 — and the standard of care must reflect that difference with objective, personalized assessment.

ClearGazeTest provides a baseline neurological assessment when a senior is well, serial monitoring as they age, and post-injury evaluation after any fall or head impact — creating a longitudinal record that gives physicians objective data to act on.

👁️ What Eye Movements Reveal About Aging

As the brain ages, eye movement biomarkers shift in characteristic ways: saccadic latency increases, smooth pursuit gain decreases, and pupillary light reflex velocity slows. These changes mirror the underlying neurology of aging — and accelerated change signals something more significant than typical aging.

🧠 The Dementia Early Warning Signal

Multiple peer-reviewed studies have demonstrated that oculomotor biomarker changes — particularly anti-saccade error rates and fixation instability — appear in Mild Cognitive Impairment (MCI) and early Alzheimer's disease years before standard cognitive screening detects decline. ClearGazeTest's biomarkers include these sensitive early markers.

⚖️ Falls and TBI in Older Adults: The Hidden Severity

A ground-level fall — falling from standing height — is the most common cause of TBI hospitalization in adults over 65. Because older adults often minimize or forget the head impact, TBI goes unrecognized and untreated. Objective assessment after any fall event, regardless of apparent severity, is the standard that emerging evidence supports.

💊 Medication Effects on Brain Function

Older adults take an average of 5+ prescription medications. Many — including benzodiazepines, antihistamines, opioids, and certain antidepressants — produce measurable oculomotor impairment that directly increases fall risk. ClearGazeTest objectively documents medication-related functional changes.

What to Watch For

Signs That Warrant Objective Assessment

These symptoms in an older adult can each reflect underlying neurological change — and all of them show up in ClearGazeTest's biomarker data before they become crises.

⚖️
Balance & Movement

Physical Changes

  • Unsteady gait or shuffling
  • Difficulty on stairs or uneven ground
  • Grabbing walls or furniture
  • Dizziness when standing
  • Slowed turning or pivoting
  • Near-falls or actual falls
🧩
Cognitive & Processing

Mental Changes

  • Word-finding difficulties
  • Forgetting recent conversations
  • Getting lost in familiar places
  • Slowed decision-making
  • Difficulty following complex tasks
  • Increased confusion after illness
👀
Vision & Eyes

Visual Symptoms

  • Blurred or double vision
  • Difficulty reading or tracking
  • Sensitivity to light or glare
  • Trouble seeing in low light
  • Difficulty judging distances
  • Eyes feeling "off" or strained
😴
Energy & Mood

Behavioral Shifts

  • Unusual fatigue or drowsiness
  • Withdrawal from social activities
  • Increased irritability
  • Apathy or loss of motivation
  • Sleep pattern changes
  • Mood swings or personality change
🚨

Go to Emergency Care Immediately If You Notice:

Sudden severe headache
Loss of consciousness (any duration)
Repeated vomiting after a fall
One pupil larger than the other
Sudden confusion or agitation
Slurred speech or facial drooping
Weakness on one side of the body
Seizure or uncontrolled movement
Cannot be woken up or roused
Who This Serves

For the Senior, the Family,
and the Care Team

Brain health assessment in older adults serves three overlapping groups — each with different needs, but all benefiting from the same objective data.

👴
Older Adults & Their Families
The primary patient · Family caregivers

For seniors who want to understand their brain health proactively — and for adult children who are watching a parent change and want objective answers, not just reassurance. A baseline assessment when a parent is well creates the comparison point that makes later assessments meaningful. Know what "normal" looks like for your loved one before a crisis happens.

🏥
Assisted Living & Memory Care
Care facility administrators · Nursing directors

For assisted living communities, memory care facilities, and skilled nursing programs that want objective, documented fall risk assessment for every resident. Serial ClearGazeTest screening creates a longitudinal neurological record that informs care planning, fall prevention protocols, and family communication — and protects the facility with documented evidence-based assessment.

👩‍⚕️
Geriatricians & Primary Care
Physicians · NPs · Occupational therapists

For geriatricians, PCPs, neurologists, and occupational therapists who manage aging patients and need objective neurological data beyond the Mini-Mental State Exam. ClearGazeTest's biomarker output integrates into clinical workflows as a rapid, non-invasive assessment that adds objective neurological dimension to the standard geriatric evaluation — and tracks change over time with quantified precision.

The Science

What 5 Minutes of Eye Tracking Reveals

ClearGazeTest uses VR-based video-oculography to measure 12 neurological biomarkers — each reflecting a specific brain system relevant to aging, fall risk, and cognitive function.

🎯
Baseline When Well, Track Over Time
The most valuable use of ClearGazeTest in older adults is longitudinal monitoring — establishing a baseline when cognition is intact and tracking biomarker values annually or semi-annually. Change over time is the signal that matters.
🏃
Fall Risk Prediction
Gaze stabilization, vestibulo-ocular reflex efficiency, and fixation stability are directly correlated with fall risk in older adults. ClearGazeTest quantifies these before a fall happens — enabling proactive intervention.
🧠
Early Cognitive Decline Detection
Anti-saccade error rates and fixation instability are among the earliest measurable changes in MCI and Alzheimer's disease — appearing years before standard cognitive screening tools detect decline.
🤕
Post-Fall Neurological Assessment
After any fall involving head impact, ClearGazeTest documents the neurological state immediately after — catching TBI that would otherwise go undetected because the senior minimized the event or the emergency room found "no visible injury."
💊
Medication Effect Monitoring
Oculomotor biomarkers sensitively reflect the neurological effects of medications. Assessing a patient after starting a new medication — particularly sedatives, opioids, or benzodiazepines — objectively documents any functional impairment that increases fall risk.
👁️
Saccade Latency
Aging & cognitive marker
Smooth Pursuit Gain
Balance & gaze control
Anti-Saccade Error
Early dementia marker
Fixation Stability
Cerebellar function
Pupil Light Reflex
Autonomic & cortical
Re-dilation Slope
Medication effects
Contrast Sensitivity
Night vision / falls
Convergence
Depth perception
VOR Efficiency
Fall risk predictor
Hippus Oscillation
Sedation indicator
Scotopic Threshold
Low-light navigation
Reaction Latency
Cognitive processing speed
Clinical Applications

Six Ways ClearGazeTest Serves Older Adults

Each application uses the same 5-minute protocol — what changes is when it's used and what question it's answering.

📋
Annual Brain Health Baseline
Establish a neurological baseline at the annual wellness visit and compare year over year. Change over time is the most sensitive early warning signal for both cognitive decline and fall risk trajectories.
🏥
Post-Fall Assessment
After any fall involving head contact — even a "minor" one — objective neurological assessment documents the impact. Older adults routinely underreport and minimize head injury, making objective assessment essential.
🧪
Cognitive Decline Monitoring
For patients with MCI or early dementia diagnosis, serial oculomotor assessment tracks the rate of neurological change — far more sensitive and objective than MMSE or MoCA scores alone.
💊
Medication Safety Check
Before and after starting a new medication with CNS effects, assessment documents functional neurological change. Gives the prescribing physician objective data to decide whether the medication's cognitive impact warrants adjustment.
🏠
Assisted Living Admission
Establish a comprehensive neurological baseline at facility admission. Creates the comparison point for all future assessments, documenting the resident's brain health before any changes happen under care.
🚗
Driving Safety Evaluation
Visual processing speed, contrast sensitivity, and reaction latency — all measured by ClearGazeTest — are direct determinants of driving safety in older adults. Provides objective data for the difficult "driving retirement" conversation.
Common Questions

What Families and Seniors Ask Most

Standard cognitive screening tools like the MMSE and MoCA are valuable but detect change relatively late in the neurological decline process. Oculomotor biomarkers — particularly anti-saccade error rates and fixation instability — change earlier than standard cognitive screening can detect. A normal MMSE today doesn't mean things aren't changing — and ClearGazeTest can quantify whether they are, even when standard screening looks fine.

Falls themselves — particularly in older adults — are often a symptom of underlying neurological change rather than just a mechanical accident. A fall that reveals gait instability, slowed reactions, or balance disruption warrants neurological evaluation regardless of whether the head was directly struck. Additionally, older adults frequently cannot reliably report whether their head contacted a surface during a fall. Assessment after any significant fall is warranted.

Reimbursement pathways for oculomotor neurological assessment are evolving as the technology gains clinical adoption. Contact us for current information about coverage options, Medicare wellness visit integration, and out-of-pocket pricing for self-pay patients. For facilities, we can discuss program pricing that makes serial population screening economically practical.

Yes. The ClearGazeTest protocol is non-invasive, non-contact, and completed in under 5 minutes. The VR headset is lightweight and adjustable. The protocol involves following visual targets — there is no discomfort, radiation, or contrast dye involved. The assessment has been designed to be accessible to older adults with varying levels of technological experience, and staff guidance is available throughout.

Implementation in a care facility involves: baseline assessment for all residents at enrollment, semi-annual or annual repeat assessments, and triggered assessments after falls, health changes, or medication modifications. Staff training for protocol administration is straightforward, and the platform generates reports suitable for medical record documentation. Contact us through the form below to discuss your facility size, current fall risk program, and how ClearGazeTest integrates with your existing workflows.

Get Started

Take the First Step Toward Clearer Answers

Whether you're a family member concerned about a parent, a care facility looking to improve fall prevention, or a geriatrician seeking better objective tools — we'd like to talk.

🌐
🏥
Clinical Partner
ClearGazeTest · Medical Card Exam
🏠
For Care Facilities
Ask about population screening programs and facility-wide implementation
👨‍👩‍👧
For Families
Ask about baseline assessment scheduling for your loved one

Your privacy is protected. Information used solely to respond to your inquiry.